The 50th anniversary of the Finnish Institute for Verification of the Chemical Weapons Convention was recently celebrated in Helsinki, Finland. PNNL's Jonathan Forman and Raul Aranzazu attended this international event.

The new PTM-Psi workflow opens the door for uncovering molecular insights within proteomics datasets.

PNNL is one of the founding partners of the Trillion Parameter Consortium, which was formed to create reliable generative AI models.

A team of researchers from PNNL provided technical knowledge and support to test a suite of techniques that detect genetically modified bacteria, viruses, and cells.

Tumeo will lead the ChemComp project, which was awarded for Exploratory Research in Extreme Scale Science

PNNL researchers are key contributors to GAO report

High fidelity simulations enabled by high-performance computing will allow for unprecedented predictive power of molecular level processes that are not amenable to experimental measurement.

Jonathan Forman was nominated to serve on the delegation of the United States of America at the second meeting of the Working Group on Strengthening the Biological Weapons Convention.

PNNL is collaborating with Microsoft, Micron and other partners to make computational chemistry broadly available.

Glenn Fugate was selected to serve on the American Chemical Society's Science Committee.

PNNL data scientist in the Biological Sciences Division won the 2023 JSM Data Challenge Expo. The award-winning analysis focused on the ability to identify crime patterns by correlating them with historical events and trends.

At the Nonproliferation, Counterproliferation, and Disarmament Science Gordon Research Conference, researchers from PNNL shared research and scientific approaches for countering diverse threats.

The Rapid Assessment of Platform Technologies to Expedite Response project aims to prepare against future pandemics.

PNNL recently joined the Department of Homeland Security for two technical meetings exploring national security research spanning the threat realm, from chemical and biological attacks to adversarial artificial intelligence.

PNNL’s wide-ranging report maps the current nanobiotechnology landscape, flags potential concerns, and details the need for an organizing body to coordinate currently disparate disciplines.

The ChemSpace Tool, when fully developed, is intended to divide chemical space into three subsets: the detectable space, the identifiable space, and the region that includes compounds that are not detectable or identifiable.

Methods review suggests ways to use artificial intelligence and machine learning to handle missing data when integrating two or more omics approaches.

PNNL chemist Christopher Anderton recently named president-elect of the Imaging Mass Spectrometry Society (IMSS). In this new position, he will help lead the merge of IMSS with a European-based society, currently underway.

Bobbie-Jo Webb-Robertson is a leader with a PhD in decision sciences & engineering systems from Rensselaer Polytechnic Institute and experience in managing complex scientific programs and line organizations. She assumed the role 3/13/23.

Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.